FDA advisory panel OKs Pfizer vaccine for kids 5 to 11

Indonesia Berita Berita

FDA advisory panel OKs Pfizer vaccine for kids 5 to 11
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 NBCNews
  • ⏱ Reading Time:
  • 34 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 86%

NBC News Special Report: FDA advisory panel recommends Pfizer's Covid vaccine for emergency use in kids ages 5 to 11.

cleared its first regulatory hurdle Tuesday for use in young children, after a Food and Drug Administration advisory committee voted to recommend it for emergency use authorization for those ages 5 to 11.

Committee member Dr. Cody Meissner, a professor of pediatrics at Tufts University School of Medicine in Boston, agreed. "It just seems to me that in some ways, we’re vaccinating children to protect the adults, and it should be the other way around," said committee member Dr. James Hildreth, president and CEO of Meharry Medical College in Tennessee."I do believe that children at highest risk do need to be vaccinated. But vaccinating all of the children ... that seems a bit that much for me."

Dr. Paul Offit, a vaccine researcher at Children’s Hospital of Philadelphia and a committee member, acknowledged the difficulty of the decision.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

NBCNews /  🏆 10. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

COVID-19 live updates: FDA panel hours away from vote on Pfizer vaccine for kidsCOVID-19 live updates: FDA panel hours away from vote on Pfizer vaccine for kidsAn independent FDA advisory panel will debate and vote on whether to authorize the Pfizer vaccine for children ages 5 to 11. The nonbinding vote is expected between 4:30 p.m. and 5 p.m. ET today.
Baca lebih lajut »

U.S. FDA advisers weigh Pfizer/BioNTech COVID-19 vaccine in childrenU.S. FDA advisers weigh Pfizer/BioNTech COVID-19 vaccine in childrenAn expert panel will weigh authorization of Pfizer Inc and BioNTech's COVID-19 vaccine for U.S. children aged 5 to 11 on Tuesday as it prepares to vote on a recommendation for the federal Food and Drug Administration.
Baca lebih lajut »

FDA Says Pfizer Vaccine Benefits Outweigh Risks In Kids 5 To 11FDA Says Pfizer Vaccine Benefits Outweigh Risks In Kids 5 To 11FDA Says Pfizer Vaccine Benefits Outweigh Risks In Kids 5 To 11 “Kids could be fully vaccinated by Christmas.”🎄
Baca lebih lajut »

Live updates of FDA meeting on Pfizer's Covid vaccines for kids ages 5 to 11Live updates of FDA meeting on Pfizer's Covid vaccines for kids ages 5 to 11The FDA's key advisors on vaccines meet today to discuss and vote on Pfizer's Covid vaccine for kids.
Baca lebih lajut »



Render Time: 2025-03-15 15:12:12